Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Receivables: 2023

Historic Receivables for CG Oncology (CGON) over the last 1 years, with Dec 2023 value amounting to $92,000.

  • CG Oncology's Receivables rose 275.91% to $515,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 176.42%. This contributed to the annual value of $92,000 for FY2023, which is N/A change from last year.
  • CG Oncology's Receivables amounted to $92,000 in FY2023.
  • In the past 5 years, CG Oncology's Receivables registered a high of $92,000 during FY2023, and its lowest value of $92,000 during FY2023.
  • In the last 1 years, CG Oncology's Receivables had a median value of $92,000 in 2023 and averaged $92,000.